AVRO AVROBIO Chart, History Price & Graph

a developer of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose

Industry: #Biotechnology

Get AI intraday signals

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for AVRO

View a ticker or compare two or three

Compare

Interact to see
Advertisement